Population Pharmacokinetics of Ganciclovir in Solid-Organ Transplant Recipients Receiving Oral Valganciclovir

Valganciclovir (VGC) is an oral prodrug of ganciclovir (GCV) recently introduced for prophylaxis and treatment of cytomegalovirus infection. Optimal concentration exposure for effective and safe VGC therapy would require either reproducible VGC absorption and GCV disposition or dosage adjustment bas...

Full description

Saved in:

Bibliographic Details
Main Authors:	Perrottet, N., Csajka, C., Pascual, M., Manuel, O., Lamoth, F., Meylan, P., Aubert, J. D., Venetz, J. P., Soccal, P., Decosterd, L. A., Biollaz, J., Buclin, T.
Format:	Artigo
Language:	Inglês
Published:	American Society for Microbiology (ASM) 2009
Subjects:	Antiviral Agents
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC2704634/ https://ncbi.nlm.nih.gov/pubmed/19307355 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00836-08
Tags:	Add Tag No Tags, Be the first to tag this record!

Population Pharmacokinetics of Ganciclovir in Solid-Organ Transplant Recipients Receiving Oral Valganciclovir

Similar Items